Do you want to remove all your recent searches?

All recent searches will be deleted

AstraZeneca Fends Off Pfizer With New Growth Plan

4 years ago4 views



AstraZeneca has outlined plans to grow annual sales to more than $45 billion by 2023 as an independent company, days after the drugmaker rejected a takeover bid by rival Pfizer. In an update to shareholders, AstraZeneca said investors would share the benefits of a "strong and consistent revenue growth" projected for 2017-2023.